. 2022; 39(3): 204-205 | DOI: 10.4274/tjh.galenos.2022.2022.0247 | |||
Kronik Myeloid Lösemi Tedavisine Yanıt Tahmininde Başlangıç BCR: : ABL1 Düşüş HızıSusan BranfordCentre for Cancer Biology, SA Pathology, Adelaide, Australia; University of South Australia, School of Pharmacy and Medical Science, Adelaide, Australia; University of Adelaide, School of Medicine, Adelaide, AustraliaInitial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid LeukemiaSusan BranfordCentre for Cancer Biology, SA Pathology, Adelaide, Australia; University of South Australia, School of Pharmacy and Medical Science, Adelaide, Australia; University of Adelaide, School of Medicine, Adelaide, AustraliaSusan Branford. Initial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia. . 2022; 39(3): 204-205 Sorumlu Yazar: Susan Branford, Australia |
|